Schedule 13G ownership disclosure

Quoin Pharmaceuticals, Ltd.

Security class unavailable · CUSIP: 74907L201

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
50
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000769993-23-000282
Form type
SC 13G/A
Filer
GOLDMAN SACHS GROUP INC
CIK
CIK 886982
Filed
Feb 14, 2023
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub